PARTUSISTEN (Partusisten).

     Chemically partusisten with fenoterolu (see) is a well-known b-adrenostimulyatorov.

     He has characterized preparations for the group pharmacological properties, including the ability to tokoliticheskoe effect.

     Experience with partusistena shows that it is an effective way to eliminate the threat of premature birth and therefore have no negative impact on the fetus and newborn.

     Assign intravenously (kapelno) and the interior as tablets. Shortly after the start of intravenous usually indicates a significant decrease in pain, the stress is removed uterus, and then completely stopped the pain and reduce the uterus.

     Inside take on the 5 mg every 2 to 3 hours; Daily dose to 40 mg. With high sensitivity (a tachycardia, muscle weakness, etc.) to reduce the dose off 2, 5 mg, a day to 30 mg. Duration of treatment 1 - 3 weeks. Intravenous impose kapelno (0.5 mg in 250 ml - 500 5% glucose solution for 15 to 20 drops per minute to sokratitelnoy oppression of the uterus).

     There is also information on the effective use of candles with partusistenom (containing 5 mg drug; From 1 to 4 times a day) for the prevention of the generic weakness for women with long preliminary period.

     Partusisten apply to facilities under close medical supervision.

     The product can cause tachycardia, hand tremor, muscle weakness, the decline in AD, sweatiness, nausea, vomiting. It has been observed that the side effects are reduced by izoptina (verapamila) - 30 mg intravenously.

     Contraindications: heart defects, heart rhythms violations, thyrotoxicosis, glaucoma.

     The issue of side effects and other partusistena tokolitikov requires further study. In an experiment could provide partusisten embriotoksicheskoe effect.

Materials allowed to copy only with the active hyperlink to the handbook of medicines